NXTC
Price:
$2.02
Market Cap:
$5.41M
NextCure, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative immunotherapies. Its core mission is to combat cancer and various other immune-related conditions by reactivating normal immune system function. The company's leading investigational compound, NC318, is currently in Phase II clinical trials, focusing on the treatment of advanced or metastatic solid tumors. Additionally, NextCure is progressing NC410 through Phase I studies; this novel immunomedicine is engineered to counteract immune suppression mediated by Leukocyte-Associated Immunoglobulin-like Receptor 1 (LAIR-1). Another asset, NC762, is an immunotherapeutic designed to target the...[Read more]
Industry
Biotechnology
IPO Date
2019-05-09
Stock Exchange
NASDAQ
Ticker
NXTC
According to NextCure, Inc.’s latest financial reports and current stock price. The company's current ROE is -186.96%. This represents a change of 304.56% compared to the average of -46.21% of the last 4 quarters.
The mean historical ROE of NextCure, Inc. over the last ten years is -31.67%. The current -186.96% ROE has changed 490.41% with respect to the historical average. Over the past ten years (40 quarters), NXTC's ROE was at its highest in in the December 2018 quarter at 14.62%. The ROE was at its lowest in in the June 2025 quarter at -84.71%.
Average
-31.67%
Median
-29.73%
Minimum
-159.81%
Maximum
63.37%
Discovering the peaks and valleys of NextCure, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 138.58%
Maximum Annual ROE = 63.37%
Minimum Annual Increase = -121.61%
Minimum Annual ROE = -159.81%
| Year | ROE | Change |
|---|---|---|
| 2025 | -159.81% | 88.01% |
| 2024 | -85.00% | 55.07% |
| 2023 | -54.82% | 22.89% |
| 2022 | -44.61% | 50.04% |
| 2021 | -29.73% | 138.58% |
| 2020 | -12.46% | 18.75% |
| 2019 | -10.49% | -121.61% |
| 2018 | 48.57% | -23.36% |
The current ROE of NextCure, Inc. (NXTC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-99.88%
5-year avg
-74.80%
10-year avg
-31.67%
NextCure, Inc.’s ROE is less than Q32 Bio Inc. (230.68%), greater than Plus Therapeutics, Inc. (-198.48%), greater than Boundless Bio, Inc. (-53.60%), greater than Verrica Pharmaceuticals Inc. (-1136.50%), greater than AN2 Therapeutics, Inc. (-52.35%), greater than Jasper Therapeutics, Inc. (-523.04%), greater than Intensity Therapeutics, Inc. (-136.82%), less than Pluri Inc. (203.55%), greater than TAO Synergies Inc. (-120.29%), less than Iterum Therapeutics plc (602.38%),
| Company | ROE | Market cap |
|---|---|---|
| 230.68% | $152.04M | |
| -198.48% | $10.16M | |
| -53.60% | $32.12M | |
| -1136.50% | $59.97M | |
| -52.35% | $137.01M | |
| -523.04% | $7.36M | |
| -136.82% | $7.39M | |
| 203.55% | $18.16M | |
| -120.29% | $12.06M | |
| 602.38% | $1.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NextCure, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NextCure, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NextCure, Inc.'s ROE?
How is the ROE calculated for NextCure, Inc. (NXTC)?
What is the highest ROE for NextCure, Inc. (NXTC)?
What is the 3-year average ROE for NextCure, Inc. (NXTC)?
What is the 5-year average ROE for NextCure, Inc. (NXTC)?
How does the current ROE for NextCure, Inc. (NXTC) compare to its historical average?